BioSpace News Archive

Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced significant progress in its role as Data Coordinating Center for studies conducted under the Best Pharmaceuticals for Children Act (BPCA).

Circularity Healthcare announced it had successfully executed a contract with the Professional Educational Research Institute (PERI) in 2020 to immediately begin a new clinical trial to study the use of D’OXYVA® to help prevent amputations and treat human diabetic foot ulcers at one-tenth the time and cost, and at least five times the efficacy of competing modalities

Three companies founded or co-founded by Truffle represent 30% of the total valuation of the highest BioMedTech market caps of Euronext Paris. They are also among the 2020 top stock performers.

The Choroideremia Research Foundation (CRF) is pleased to announce funding for its first research study in 2021 to Mariya Moosajee, MBBS, BsC (Hons), PhD, FRCOphth.

Protech Home Medical Corp., a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, announced its fourth quarter and audited full year fiscal 2020 financial results and operational highlights for the period ended September 30, 2020.

Neogen Corporation (NASDAQ: NEOG) announced today that it has relaunched its popular ThyroKare™ (levothyroxine sodium tablets), USP, which are approved by the FDA for replacement therapy for diminished thyroid function in dogs.

University of Memphis integrates Movendo Technology’s robotic system hunova© into baseline screening and physical rehabilitation of their student athletes.

Chiesi, an international research-focused Healthcare group (Chiesi Group), announces that the European Commission has granted the marketing authorization for Chiesi extrafine triple therapy combination ICS/LABA/LAMA in a single inhaler, for the treatment of asthma.

Olympus Corporation announced the launch of a new comprehensive educational platform designed to provide healthcare professionals all over the world with learning opportunities and training to put their skills into practice and keep them performing at their best.

Innova Medical Group, Inc., the world’s largest manufacturer of rapid antigen test kits and leader in COVID-19 testing solutions globally, confirmed today that the company’s SARS-CoV-2 Antigen Test kits have successfully detected the several mutated strains that have become more widespread around the world in recent weeks.